VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,281,000 | -0.5% | 512,051 | +10.8% | 0.93% | +47.3% |
| Q4 2015 | $4,302,000 | -25.7% | 462,051 | -10.0% | 0.63% | -14.7% |
| Q3 2015 | $5,791,000 | -11.1% | 513,390 | 0.0% | 0.74% | +15.8% |
| Q2 2015 | $6,515,000 | +28.9% | 513,390 | -5.5% | 0.64% | +21.3% |
| Q1 2015 | $5,054,000 | -4.2% | 543,390 | +47.5% | 0.53% | -41.5% |
| Q4 2014 | $5,275,000 | +132.7% | 368,390 | +68.7% | 0.90% | +221.1% |
| Q3 2014 | $2,267,000 | +0.1% | 218,390 | +56.0% | 0.28% | -49.8% |
| Q2 2014 | $2,265,000 | +114.5% | 140,000 | +115.4% | 0.56% | +131.5% |
| Q1 2014 | $1,056,000 | -10.4% | 65,000 | -31.6% | 0.24% | -26.5% |
| Q4 2013 | $1,179,000 | – | 95,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |